Jefferies Financial Group’s Coherus Oncology CHRS Stock Holding History

Jefferies Financial Group’s Portfolio CHRS Stock Details CHRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$232K	Hold
2025 Q1	$256K	Buy
2024 Q4	$425K	Buy
2024 Q3	$294K	Buy
2024 Q2	$340K	Hold
2024 Q1	$470K	Buy
2023 Q4	$278K	Buy
2023 Q3	$152K	Buy
2023 Q2	–	Sell
2023 Q1	$893K	Buy
2022 Q4	$195K	Buy